Stockreport

Day One to buy Mersana Therapeutics for $25/share upfront [Seeking Alpha]

Mersana Therapeutics, Inc.  (MRSN) 
Last mersana therapeutics, inc. earnings: 2/28 06:00 am Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF biopharmaceutical company Mersana Therapeutics ( MRSN ) in a deal value of up to around $285 million. Shares of Mersana Therapeutics ( MRSN ) jumped premarket to $27.6 [Read more]